Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist
{{output}}
Rivaroxaban is a direct oral anticoagulant (DOAC) indicated to reduce risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). A discrepancy exists between the recommended dosage and real-world use of DOACs, especially rivar... ...
